We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Ooh la la! Christina Haack (formerly Hall) revealed she and boyfriend Chris Larocca were on a romantic vacation in Paris, France, after flying out of LAX two days prior. The HGTV star, 41 ...

Vertex Pharmaceuticals (NASDAQ: VRTX) is a biotechnology company with a strong track record of success in developing treatments for cystic fibrosis (CF). Vertex is strategically expanding into the ...

Christina Haack has learned some marriage lessons the hard way. The "Flip or Flop" star, 41, opened up on "Jeff Lewis Live" this week about her less-than-three-year-marriage to husband Josh Hall ...

Keith Speights has positions in Vertex Pharmaceuticals. The Motley Fool has positions in and recommends Vertex Pharmaceuticals. The Motley Fool has a disclosure policy. Why This Beaten-Down Growth ...

The most recent trading session ended with Vertex Pharmaceuticals (VRTX) standing at $416.96, reflecting a -1.72% shift from the previouse trading day's closing. The stock's performance was behind ...

Don't let her last name fool you, Christina Haack (former Hall) wants nothing to do with her ex Josh Hall. Though the former couple — who have become estranged and seemingly have a bitter trial ...

Christina Haack's new man Christopher Larocca's ex has revealed details of her relationship with the businessman that she claims 'ended three months ago.' In an exclusive interview with DailyMail ...

Christina Haack (formerly Hall) and boyfriend Chris Larocca were spotted for the first time in public, as the duo confirmed their romance while boarding a plane together amid her bitter divorce ...

Vertex Pharmaceuticals (VRTX) comes in second with a score of 4.04 and a Buy rating given its dominance in the cystic fibrosis treatment category and diversified pipeline, making a compelling case ...